Former health secretary and now Iloilo 1st district Rep. Janette Garin supports Malacañang Palace’s call on Food and Drug Administration (FDA) to test the Fabunan Antiviral Injection (FAI) if it is effective for use in the treatment of COVID-19. 

Recently, the Palace calls FDA to study the efficacy of this Fabunan Antiviral Injection, which was reportedly developed by Washington-based Filipino doctor Ruben Fabunan. According to Garin, she fully supports Malacanang’s call to have the Fabunan viral injection studied by the FDA. Is it indeed an effective cure? Is it under clinical trial? If it’s for clinic use, there should still be medical transparency. “If this viral injection is what it claims to be, then let’s have the FDA study its effectiveness and make a pronouncement whether it’s safe or not,” she added. 

Garin warned the public against trending posts about COVID-19 cures, “At this point, the world is desperate for a cure but we should also be careful and avoid unnecessary medical expenses. We should be wary of the things we read, see or watch in social media.” 

Last April 8, 2020, On the official website of the FDA the agency recognizes the Fabunan Antiviral Injection and is required to submit necessary legal documents for approval if the said Antiviral Injection will pass the test this could be safe to use for treating COVID-19 disease.  

Manufacturers and vendors of unlicensed products such as PRODEX B and the Fabunan antiviral injections have been informed regarding the process and requirements to register their products with the FDA Center for Drug Regulation and Research (CDRR). 

“No applications for product registration have been filed to date. Until such products are proven safe and effective for use in the treatment of COVID-19 they cannot be dispensed to the public nor can therapeutic claims be made,” it added. 

Share your thoughts and commend in the discussion box below.